Matt Rasberry, RD

The Utilization of Sepiapterin to Potentially Lower Phenylalanine Levels and Increase Protein Tolerance in Individuals with Phenylketonuria (PKU)

  • Summarize the pathophysiology of PKU and the current management options for individuals with PKU.
  • Evaluate the recent literature on Sepiapterin's potential ability to lower phenylalanine levels and increase protein tolerance for individuals with Phenylketonuria.
  • Identify how Sepiapterin will be implemented in the Biochemical Genetics Clinic at the Waisman Center.

 

Tonisha Atkins, BA

Grace Anbouba, MS, CGC

Clinical and Ethical Considerations of NEXN Variants in the Prenatal Setting: Recurrent Pregnancy Loss and Duty to Warn

  • Analyze the clinical implications of NEXN variants in prenatal and adult settings.
  • Evaluate competing ethical obligations related to duty to warn amid complex family structures and psychosocial factors.
Session date: 
02/25/2026 - 4:00pm to 5:00pm CST
Location: 
Virtually
WI 53705
United States
See map: Google Maps
  • 1.00 AAPA Category 1 CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 CDR CPEUs
  • 1.00 NSGC Category 1 CEU Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Matt Rasberry, RD
Tonisha Atkins, BA (grad student)
Grace Anbouba, MS, CGC